Literature DB >> 29414304

Thyroid hormone in the regulation of hepatocellular carcinoma and its microenvironment.

P Manka1, J D Coombes2, R Boosman3, K Gauthier4, S Papa5, W K Syn6.   

Abstract

Hepatocellular carcinoma (HCC) commonly arises from a liver damaged by extensive inflammation and fibrosis. Various factors including cytokines, morphogens, and growth factors are involved in the crosstalk between HCC cells and the stromal microenvironment. Increasing our understanding of how stromal components interact with HCC and the signaling pathways involved could help identify new therapeutic and/or chemopreventive targets. It has become increasingly clear that the cross-talk between tumor cells and host stroma plays a key role in modulating tumor growth. Emerging reports suggest a relationship between HCC and thyroid hormone signaling (dysfunction), raising the possibility that perturbed thyroid hormone (TH) regulation influences the cancer microenvironment and cancer phenotype. This review provides an overview of the role of thyroid hormone and its related pathways in HCC and, specifically, its role in regulating the tumor microenvironment.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Liver cancer; Liver fibrogenesis; Thyroid hormone; Tumor microenvironment

Mesh:

Substances:

Year:  2018        PMID: 29414304     DOI: 10.1016/j.canlet.2018.01.055

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  LNA Inhibitor in microRNA miR-23b as a Potential Anti-proliferative Option in Human Hepatocellular Carcinoma.

Authors:  Zoya Najafi; Mohammadreza Sharifi; Gholamreza Javadi
Journal:  J Gastrointest Cancer       Date:  2020-03

Review 2.  Targeting Thyroid Hormone/Thyroid Hormone Receptor Axis: An Attractive Therapy Strategy in Liver Diseases.

Authors:  Qianyu Tang; Min Zeng; Linxi Chen; Nian Fu
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

3.  Exploration of Sorafenib Influences on Gene Expression of Hepatocellular Carcinoma.

Authors:  Huancheng Wang; Jia Liu
Journal:  Front Genet       Date:  2020-10-08       Impact factor: 4.599

4.  Systematically Exploring the Antitumor Mechanisms of Core Chinese Herbs on Hepatocellular Carcinoma: A Computational Study.

Authors:  Zhulin Wu; Li He; Lianan Wang; Lisheng Peng
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-15       Impact factor: 2.629

5.  Can network pharmacology identify the anti-virus and anti- inflammatory activities of Shuanghuanglian oral liquid used in Chinese medicine for respiratory tract infection?

Authors:  Zhenjie Zhuang; Junmao Wen; Lu Zhang; Mingjia Zhang; Xiaoying Zhong; Huiqi Chen; Chuanjin Luo
Journal:  Eur J Integr Med       Date:  2020-05-26       Impact factor: 1.314

Review 6.  Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options.

Authors:  Daniela Maria Tanase; Evelina Maria Gosav; Ecaterina Neculae; Claudia Florida Costea; Manuela Ciocoiu; Loredana Liliana Hurjui; Claudia Cristina Tarniceriu; Mariana Floria
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

7.  AATF and SMARCA2 are associated with thyroid volume in Hashimoto's thyroiditis patients.

Authors:  Luka Brčić; Ana Barić; Benjamin Benzon; Marko Brekalo; Sanda Gračan; Dean Kaličanin; Veselin Škrabić; Tatijana Zemunik; Maja Barbalić; Ivana Novak; Valdi Pešutić Pisac; Ante Punda; Vesna Boraska Perica
Journal:  Sci Rep       Date:  2020-02-04       Impact factor: 4.379

Review 8.  Roles of Thyroid Hormone-Associated microRNAs Affecting Oxidative Stress in Human Hepatocellular Carcinoma.

Authors:  Po-Shuan Huang; Chia-Siu Wang; Chau-Ting Yeh; Kwang-Huei Lin
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923

9.  Exploring the Mechanisms of Arsenic Trioxide (Pishuang) in Hepatocellular Carcinoma Based on Network Pharmacology.

Authors:  Xinmiao Wang; Luchang Cao; Jingyuan Wu; Guanghui Zhu; Xiaoyu Zhu; Xiaoxiao Zhang; Duoduo Han; Ning Shui; Baoyi Ni; Jie Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-29       Impact factor: 2.629

10.  Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma.

Authors:  Jinyuan Shi; Pu Wu; Lei Sheng; Wei Sun; Hao Zhang
Journal:  Cancer Cell Int       Date:  2021-12-14       Impact factor: 5.722

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.